REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 172 filers reported holding REGENXBIO INC in Q1 2023. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $41 | -14.6% | 2,590 | +4.3% | 0.00% | – |
| Q2 2023 | $48 | -57.9% | 2,483 | -59.4% | 0.00% | – |
| Q1 2023 | $114 | -45.2% | 6,114 | -33.7% | 0.00% | – |
| Q4 2022 | $208 | -99.9% | 9,224 | -10.0% | 0.00% | – |
| Q3 2022 | $270,000 | +12.5% | 10,251 | +5.2% | 0.00% | – |
| Q2 2022 | $240,000 | +10.1% | 9,746 | +47.9% | 0.00% | – |
| Q1 2022 | $218,000 | +230.3% | 6,588 | +222.9% | 0.00% | – |
| Q4 2021 | $66,000 | -58.8% | 2,040 | -46.9% | 0.00% | – |
| Q3 2021 | $160,000 | +63.3% | 3,839 | +50.8% | 0.00% | – |
| Q2 2021 | $98,000 | +9700.0% | 2,546 | +4796.2% | 0.00% | – |
| Q1 2021 | $1,000 | -98.7% | 52 | -97.0% | 0.00% | – |
| Q4 2020 | $79,000 | +107.9% | 1,759 | +25.4% | 0.00% | – |
| Q3 2020 | $38,000 | -47.2% | 1,403 | -28.9% | 0.00% | – |
| Q2 2020 | $72,000 | +18.0% | 1,972 | +31.8% | 0.00% | – |
| Q4 2019 | $61,000 | -95.5% | 1,496 | -92.1% | 0.00% | -100.0% |
| Q2 2018 | $1,358,000 | – | 18,932 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sonic Fund II, L.P. | 263,786 | $7,259,000 | 5.10% |
| ArchPoint Investors | 298,404 | $8,212,000 | 2.62% |
| Burrage Capital Management LLC | 116,405 | $3,203,000 | 2.53% |
| P.A.W. CAPITAL CORP | 75,000 | $2,064,000 | 2.25% |
| Aquilo Capital Management, LLC | 510,760 | $14,056,000 | 1.49% |
| WS MANAGEMENT LLLP | 436,828 | $12,022,000 | 1.30% |
| Redmile Group, LLC | 2,228,166 | $61,319,000 | 1.13% |
| Ghost Tree Capital, LLC | 75,000 | $2,064,000 | 0.60% |
| FRAZIER MANAGEMENT LLC | 174,200 | $4,794,000 | 0.43% |
| Woodline Partners LP | 275,442 | $7,580,000 | 0.25% |